Glucosamine medication

RX_GLUCOSAMINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC M01AX05

1 out of 7 registries used, show all original rules.

20126

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

20126

diagram downward connector

Include endpoints None

20126

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

19596

diagram downward connector
RX_GLUCOSAMINE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 19596 13705 5891
Unadjusted prevalence (%) 4.76 5.95 3.24
Mean age at first event (years) 60.32 59.83 61.47

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.39 [1.19, 1.62] 2.2e-5 2416
15 years 0.01 1.24 [1.07, 1.44] 3.9e-3 1883
5 years 0.00 0.92 [0.78, 1.07] 2.7e-1 326
1 year 0.00 0.30 [0.18, 0.48] 5.5e-7 18

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_GLUCOSAMINE – Glucosamine medication
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Glucosamine medication
after Glucosamine medication

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Glucosamine medication

↥

Endpoint not on priority list, no data to show.